Remove companies therapeutics-inc
article thumbnail

Battle Lines Are Drawn on Noncompete Ban

Intelligize Blog

In a move cheered by labor interests across the United States, the FTC approved a measure last month prohibiting employers from using contracts to prevent their workers from moving to rival companies. How do publicly traded companies themselves feel about noncompete agreements? It took roughly 24 hours for the U.S. and FTI Consulting.

article thumbnail

Harpoon Shareholder Sues For Records On $680M Merck Buy

Law 360

A shareholder of Harpoon Therapeutics Inc. sued in Delaware's Court of Chancery Thursday for corporate documents related to the company's proposed $680 million cash buyout by Merck, saying the proposed deal appears to unfairly "lock in a windfall for select Harpoon investors."

Court 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ex-Biopharma CEO Sues For Post-Sale Share Appraisal In Del.

Law 360

The co-founder of Caraway Therapeutics Inc. sued in Delaware's Court of Chancery on Tuesday for an appraisal of his shares following the company's November merger with a subsidiary of pharmaceutical giant Merck, alleging that it "was an unfair cash-out transaction" and that he is owed at least a million more shares.

Court 52
article thumbnail

Esperion Snags $125M Deal With Daiichi On Cholesterol Drug

Law 360

Esperion Therapeutics Inc. on Wednesday announced a $125 million deal with a Japanese pharmaceutical giant to resolve Esperion's demand for $300 million from the company over Esperion's cholesterol reduction drugs.

52
article thumbnail

Del. Court Trims Biotech Investors' Stock Transfer Suit

Law 360

Biotech company Frequency Therapeutics Inc. can't beat an investor suit accusing it of failing to transfer certain company shares until trading prices for those shares plummeted, a Delaware state judge ruled Thursday, although he did trim some claims.

Court 73
article thumbnail

Chancery Finds Drug Exec Breached Pact With Sorrento

Law 360

A veteran drug company executive misappropriated trade secrets and breached his noncompete pact while employed at a business he co-founded that was bought by Sorrento Therapeutics Inc. when he started another company on the side, Delaware's Court of Chancery has ruled.

Court 52
article thumbnail

Paul Hastings, Covington Guide Kyverna's Upsized $319M IPO

Law 360

Cell therapy firm Kyverna Therapeutics Inc. was set to begin trading Thursday after completing an upsized $319 million initial public offering above its price range, guided by Paul Hastings LLP and underwriters counsel Covington & Burling LLP, marking the latest life sciences company to go public.

40